Richard J Lush - JoVE Visualize

Showing results (1-10 of 1) with videos related to

Pageof 1

Sort By:

British Journal of Haematology|February 23, 2007

Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin diseaseMark J Bishton, Richard J Lush, Jenny L Byrne, et al.

Pageof 1

Showing results (1-10 of 1) with videos related to

Sort By:

Pageof 1

British Journal of Haematology|February 23, 2007

Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin diseaseMark J Bishton, Richard J Lush, Jenny L Byrne, et al.

Pageof 1